Elanco 동물 건강 법인
MX ˙ BMV ˙ US28414H1032
SecurityMX:ELAN / Elanco Animal Health Incorporated
InstitutionCAPROCK Group, Inc.
Latest Disclosed Ownership58,133 shares
Latest Disclosed Value $ 1,391,134
CAPROCK Group, Inc. reports 11.50% increase in ownership of ELAN / Elanco Animal Health Incorporated

On May 11, 2026 - CAPROCK Group, Inc. filed a 13F-HR form disclosing ownership of 58,133 shares of Elanco Animal Health Incorporated (MX:ELAN) valued at $1,391,134 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 52,135 shares of Elanco Animal Health Incorporated. This represents a change in shares of 11.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 58,133 5,998 11.50 1,391 17.98 0.0338
2026-01-28 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 52,135 32,634 167.35 1,180 230.25 0.0249
2025-11-06 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 19,501 19,501 358 0.0088
2025-05-15 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 0 -11,637 -100.00 0 -100.00
2025-01-23 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 11,637 -45,443 -79.61 141 -83.29 0.0046
2024-11-07 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 57,080 -5,851 -9.30 839 -7.71 0.0305
2024-08-06 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 62,931 -5 -0.01 908 -11.33 0.0369
2024-04-29 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 62,936 -15,442 -19.70 1,025 -12.25 0.0587
2024-01-18 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 78,378 -155 -0.20 1,168 32.31 0.0746
2023-10-18 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 78,533 16 0.02 883 11.79 0.0668
2023-08-10 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 78,517 25,759 48.82 790 59.39 0.0580
2023-04-26 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 52,758 52,758 496 0.0384
2023-01-23 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 0 -13,200 -100.00 0 -100.00
2022-11-07 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 13,200 13,200 164 0.0158
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.